Exxon Mobil was upgraded by Bank of America Merrill Lynch and the raised price target caused stocks to get a lift in the morning session. However, the boost did not last long and stocks began to give back those gains. Ben Willis of Albert Fried notes many stocks being sold are ones with high margin requirements. Willis mostly sees a sector rotation happening out of the names and going into lower beta names. He also points out the biotech weakness at NASDAQ.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

More from Video

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Will Tesla CEO Elon Musk Really Pulverize the Haters?

Will Tesla CEO Elon Musk Really Pulverize the Haters?

Jim Cramer's Investing Rule #4: Buy Damaged Stocks, Not Damaged Companies

Jim Cramer's Investing Rule #4: Buy Damaged Stocks, Not Damaged Companies

Jim Cramer's Investing Rule #3: Don't Buy Stocks All at Once

Jim Cramer's Investing Rule #3: Don't Buy Stocks All at Once